Paroxysmal kinesigenic dyskinesia (PKD) (MIM 128200) is a rare paroxysmal movement disorder that occurs at an estimated prevalence of 1:150,000 individuals. 1 Onset is most commonly in childhood or adolescence, with sporadic and familial cases being reported. 2, 3 PKD is characterized by short and frequent episodes of dystonic or choreiform movements that are precipitated by sudden voluntary movements or startle. Classic clinical criteria for PKD therefore include an identifiable kinesigenic trigger, short duration of attacks, no loss of consciousness or pain during attacks, normal interictal neurologic examination results, the exclusion of other organic diseases, onset between 1 and 20 years of age (if no family history), and a response to treatment with anticonvulsants (sodium channel blockers). 3 Genetically, most cases of PKD are caused by autosomal-dominant mutations in the PRRT2 (proline-rich transmembrane protein 2; DYT10) gene, 4, 5 making PKD part of an evolving spectrum of PRRT2-associated diseases that includes benign familial infantile seizures, infantile convulsions with choreoathetosis, episodic ataxia, hemiplegic migraine, and benign paroxysmal torticollis of infancy 6 (table 1 and table e-1 on the Neurology ® Web site at Neurology.org). We briefly review the clinical presentation and genetics of movement disorders associated with PRRT2 mutations and report an illustrative case that highlights typical and atypical features as well as important differential diagnoses in a family with PRRT2-associated PKD.
Clinical history. A 15-year-old, left-handed girl presented with a 3-day history of recurrent episodes of abnormal movements. She interpreted these episodes as sudden attacks of weakness. Her legs and trunk seemed predominantly affected, whereas her arms and face were relatively spared. She retained awareness during attacks and described an aura of nonspecific discomfort precipitating her abnormal movements.
Medical history was significant for recurrent episodes of migraine with aura. The patient was born at full term after an uneventful pregnancy, reached all developmental milestones appropriately, and is currently a high school student with good grades.
On neurologic examination, the movement disorder was found to fluctuate with voluntary motor activity but was not entirely paroxysmal in nature (video 1). At rest, tone in both legs seemed to be intermittently increased, a finding that was not clearly distinguishable from intermittent voluntary movements. When attempting to walk, increased tone was observed in her limbs and trunk, without overt torsion or dystonic posturing of fingers. The patient showed a slow, unsteady, narrowbased staggering gait with a tendency to fall, and felt unable to walk without support. Her trunk showed shaking movements, possibly consistent with intermittent dyskinesias or hyperkinetic or jerky dystonia. With ongoing motor activity in tasks such as walking or climbing stairs, abnormal movements of her legs and trunk increased to an extent that prevented her from moving forward. The remainder of the neurologic examination revealed mild cerebellar-like tremor on finger-to-nose testing only. Notably, no deficit in strength was appreciable.
Laboratory studies, CSF analysis (including levels of biogenic amines, 5-10-methylenetetrahydrofolate, and pterins), and MRI scans of the patient's brain and spine revealed no abnormalities.
Family history. The patient's mother had paroxysmal dyskinesias since childhood with a frequency from multiple per day to 1 every few months. Attacks were stereotypical, with the trigger always being a sudden movement, although tiredness, anxiety, and stress would increase the likelihood. After a sudden movement, she experienced brief unilateral dystonic posturing of her arm and leg, most commonly of her right side. She was diagnosed with epilepsy and treated with phenytoin and carbamazepine, which led to a reduction in the frequency of attacks. The diagnosis of PKD, however, was only made when her son presented with similar symptoms. By then, she had few attacks despite having discontinued anticonvulsants for years. Interestingly, she reports frequent migraines with aura. The patient's brother became symptomatic at age 12 years, when he presented with paroxysmal repetitive, unilateral dystonic posturing of his right arm and leg that occurred exclusively after attempting to quickly rise to stand or walk. His dystonia was mostly limited to his right hemibody and was sometimes accompanied by twisting movements of his head and neck to his right. His interictal neurologic examination revealed no deficits and MRI including time-of-flight angiography scans was unremarkable. Attacks completely subsided with low-dosage oxcarbazepine and only returned temporarily when his weight-adapted dosage fell below 6 mg/kg/day (300 mg/day).
Genetic analysis. PCR-based Sanger sequencing was used to analyze coding exons and flanking introns of the PRRT2 gene. The patient, her brother, and her mother were found to carry a heterozygous c.649dupC, p.Arg217Profs*8 mutation in exon 2.
Clinical course and differential diagnoses. In view of the family history of classic PKD and the autosomal dominant inheritance of this disease, an atypical presentation of PKD was initially considered. A trial of low-dosage oxcarbazepine (8 mg/kg/day) was given with complete resolution of symptoms within days (video 2). Genetic testing revealed a pathogenic PRRT2 mutation in all 3 affected family members. In order to further evaluate the possibility of an atypical presentation within the growing spectrum of paroxysmal disorders associated with PRRT2 mutations vs a functional disorder (and to be able to provide proper treatment for the latter), we suggested a trial of discontinuation of therapy after 16 months of remission on oxcarbazepine. This was discussed with the family. Oxcarbazepine was discontinued and episodes did not return after a 10-month follow-up, supporting a functional movement disorder as the most likely diagnosis, although a spontaneous remission of PKD 3 cannot be ruled out definitively.
DISCUSSION This case illustrates the diagnostic challenge when faced with distinguishing an atypical phenotype within the spectrum of PRRT2-associated movement disorders from an unrelated differential diagnosis in a family with genetically confirmed PRRT2-associated PKD. Our report highlights the need to carefully evaluate differential diagnoses including functional movement disorders. This is particularly important and challenging given the remarkable interfamilial and intrafamilial pleiotropy seen in patients with PRRT2-associated movement disorders and considerable clinical overlap between subtypes of paroxysmal dyskinesias 7 (table 1 and table e-1) . Key clinical characteristics of PKD are recurrent unilateral or bilateral episodes of dystonia, choreiform movements, or ballism that are triggered by sudden voluntary movements such as initiation of walking, standing up, or being startled (table 1) . Episodes are usually brief, stereotypical, and do not involve loss of consciousness. They vary in frequency and a precipitating aura is frequently reported, sometimes allowing the patient to partially control arising episodes.
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The disease is paroxysmal with the interictal examination being unremarkable. Often, a dramatic improvement is seen with anticonvulsant treatment (sodium channel blockers) (particularly in PRRT2 mutation carriers 8 ) , making this a possible way to confirm the diagnosis. 3 The overall prognosis of PKD is good as the frequency of attacks tends to decline with age and spontaneous remission occurs in a subset of patients. 3 Important differential diagnoses for primary PKD include secondary causes such as demyelinating disease, stroke, trauma, encephalitis, hypoparathyroidism, or pseudohypoparathyroidism with basal ganglia calcification, and rarely perinatal hypoxic encephalopathy or moyamoya disease. PKD must be distinguished from diseases that might mimic its phenotype, most importantly exercise-induced dystonia (particularly GLUT1 deficiency syndrome), seizures, pseudoseizures, tics, and functional movement disorders.
Although sporadic cases are reported, primary PKD is mainly a familial disease with autosomal dominant inheritance and incomplete penetrance (;60%-90%). 9 Whereas our patient's mother and brother show the classic clinical picture of PKD, several findings in our patient are considered atypical and might point to other etiologies. Importantly, abnormal movements were not clearly paroxysmal, had no kinesigenic trigger, and were of unusual long duration. She showed a mixture of different movement disorders that did not appear to follow established patterns and fluctuated considerably. Features suggestive of a functional etiology 10 (summarized in table e-2) included a rapid onset and increment of symptom intensity and an unusually high degree of impairment, contrasting her low level of emotional involvement. Similar to the well-known coexistence of both epileptic seizures and psychogenic nonepileptic seizures within the same family or even the same patient, prior exposure to family members with a genetically determined movement disorder is a risk factor for a functional etiology in this case. On the other hand, her abnormal movements, albeit fluctuating within individual episodes, could not be subjected to distraction or exhaustion. Common features of functional movement disorders such as associated symptoms (pain, sensory deficits, or weakness), an underlying psychosocial trigger or secondary gain, a history of somatization in the past, or psychiatric illness were not discernible.
Interestingly, migraines are commonly reported in PRRT2 mutation carriers (table e-1) and hence migraines with aura in this family could be part of a PRRT2-associated phenotype. The low frequency of migraine episodes, however, did not allow us to assess a potential response to oxcarbazepine.
In conclusion, the identification of PRRT2 as a major genetic cause for a spectrum of paroxysmal neurologic diseases has allowed better disease classification and enables genetic confirmation of a clinical diagnosis in many cases (table 1 and table e-1) . However, as our report highlights, the presence of a mutation or family history does not exclude other causes such as a functional movement disorder. The diagnostic challenge is even greater, as it is almost certain that the spectrum of PRRT2-associated movement disorders is broader than we currently recognize. Our report emphasizes the need to combine a thorough clinical evaluation with the growing understanding of genetics behind complex monogenic movement disorders.
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